Updates

Kalibrate

October 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Kalibrate continues to accelerate the transition to its software as a service (SAAS) model, which means payments from users of its software are received on a monthly basis throughout the three year term of a contract instead of as a large upfront payment. For instance, in the last year, 10 clients bought its software under the SAAS model and had they closed on perpetual licence deals this would have generated perhaps US$2m-US$3m in additional licence revenue, so this is one reason why Kalibrate is never going to have a “blow the lights out” year. Kalibrate began to sell under its SAAS model three years ago and chief executive Bob Stein says it is starting to get traction. The growth of SAAS to one third of revenue ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

XL Media - Upgrading the upgrade

SQS - 11th year of growth ahead despite some pains

Kalibrate (July 2017)

Kalibrate (April 2015)

Kalibrate (October 2014)

Kalibrate - Shares on cusp of breakout (September 2014)

Kalibrate - Comfortably ahead of market forecasts (July 2014)

Kalibrate (April 2014)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X